Another Study Finds CRISPR Gene Therapy Fights Sickle Cell

Follow Drugslib on

Medically reviewed by Drugs.com.

By Ernie Mundell HealthDay Reporter

TUESDAY, June 18, 2024 -- There's more good news in the battle against sickle cell disease, with another trial finding CRISPR gene-editing therapy delivering impressive results for patients.

“It’s encouraging that this gene-editing treatment continues to show promising efficacy for sickle cell patients,” said study lead investigator Dr. Rabi Hanna. He's chair of the division of pediatric hematology oncology and blood and marrow transplantation at Cleveland Clinic Children’s.

Sickle cell anemia is a painful, inherited genetic disorder which creates misshapen sickle-shaped red blood cells. Over 100,000 Americans are thought to have sickle cell disease, which can shorten life spans and is much more common among Black Americans.

Recent advances in what's known as CRISPR gene-editing technology helps correct the disorder by tweaking the underlying gene abnormality behind it.

The Cleveland Clinic CRISPR approach is called renizgamglogene autogedtemcel (shortened to "reni-cel"). It's am experimental one-time treatment that uses the patient's own stem cells to correct the genetic abnormality.

Two of the 18 patients in the new trial were treated at the Cleveland Clinic.

In the procedure, patients' stem cells are harvested and then sent for gene editing in the lab. Patients also underwent chemotherapy to make room for the new stem cells to be infused into their bone marrow.

"Following treatment, all patients successfully regained their white blood cells and platelets," according to a clinic news release. "Importantly, all patients have remained free of painful events since treatment, and those followed for five months or greater have seen their anemia resolve."

The treatment also appeared to have no serious side effects, Hanna's group reported.

"These latest results offer hope that this new experimental treatment will continue to show progress and get us closer to a functional cure for this devastating disease," he said.

The findings were presented Thursday at the European Hematology Association 2024 Hybrid Congress (EHA) in Madrid. Such findings should be considered preliminary until published in a peer-reviewed journal.

The trial was funded by gene-editing company Editas Medicine.

Sources

  • Cleveland Clinic, news release, June 14, 2024

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2024-06-18 21:15

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords